COVID-19 updates: Moderna COVID-19 vaccine (Spikevax) gains full licensure.

MLA

“COVID-19 Updates: Moderna COVID-19 Vaccine (Spikevax) Gains Full Licensure.” The Medical Letter on Drugs and Therapeutics, vol. 64, no. 1644, Feb. 2022, p. 32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=35175715&authtype=sso&custid=ns315887.

APA

COVID-19 updates: Moderna COVID-19 vaccine (Spikevax) gains full licensure. (2022). The Medical Letter on Drugs and Therapeutics, 64(1644), 32.

Chicago

“COVID-19 Updates: Moderna COVID-19 Vaccine (Spikevax) Gains Full Licensure.” 2022. The Medical Letter on Drugs and Therapeutics 64 (1644): 32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=35175715&authtype=sso&custid=ns315887.